Background Hürthle cell neoplasms (HCNs) are rare tumors of the thyroid gland. The
definitive treatment for Hürthle cell carcinoma (HCC) is total thyroidectomy, while thyroid …

Background: The majority of patients having a diagnosis of Hürthle cell neoplasm (HCN) on
fine-needle aspiration (FNA) of a thyroid nodule have a diagnostic thyroid lobectomy to …

Objective To determine if any preoperative or intraoperative factors can reliably predict
malignancy in patients with Hürthle cell neoplasms. Summary Background Data Most …

Background A fine needle aspiration (FNA) diagnosis of a Hürthle cell neoplasm is
associated with a 20% risk of malignancy. We sought to determine if the primary tumor size …

AIMS: The objective of the study was to report a series of patients with Hürthle cell tumours.
METHODS: We reviewed medical records of single institution from January 1982 to …

Methods A total of 279 patients (241 females, 38 males; median age 55 years, range 15–86
years) with HC neoplasm in whom carcinoma was only suspected and who were surgically …

The ability to differentiate benign from malignant Hürthle cell thyroid neoplasms has
provoked considerable controversy. This has significant therapeutic implications, since …

Controversy still exists about the ability to differentiate between malignant and benign
Hürthle cell tumors (HCTs) before and during surgery. Diagnostic difficulties make surgical …

Background. Hürthle cell carcinomas of the thyroid are unusual variants of well-differentiated
thyroid cancers. Considered more aggressive tumors, their optimal treatment is …

Background. Hürthle cell tumors still pose issues concerning diagnosis and management.
Methods. From 1984 to 1993 forty-seven patients underwent thyroidectomy, and they were …